All Data
Sanofi Active Ingredient Solutions cover both APIs sales & CDMO.
Lead Product(s): MRT5500
Therapeutic Area: Infections and Infectious Diseases Product Name: MRT5500
Highest Development Status: IND Enabling Product Type: Vaccine
Partner/Sponsor/Collaborator: Translate Bio
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 15, 2020
Details:
Preclinical evaluation of MRT5500, importantly, demonstrated a favorable immune response profile against SARS-CoV-2. These data support the selection of MRT5500 for clinical development.
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): mRNA Covid-19 vaccine
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: IND Enabling Product Type: Vaccine
Partner/Sponsor/Collaborator: Tibet Rhodiola Pharmaceutical
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 05, 2021
Details:
The potential vaccine, which Stemirna has started working on since January last year, is based on messenger RNA (mRNA) technology, Tibet Rhodiola Pharma, which is jointly developing the candidate with Stemirna.